Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China

3 years ago

License fees of $5.0 million, and up to $5.0 million in unregistered equity infusion, over next 24 monthsService agreement of…

Pressure BioSciences Announces Contracted Production Launch for Estimated $3,000,000 of UST-Processed, Nanoemulsified CBD Spray for Oral Use

3 years ago

Safer Medical of Montana, a Seasoned Distributor of Wellness Products with a Focus on Veterans, Partners with PBI as Exclusive…

Aytu BioPharma Announces the Appointment of Vivian Liu to the Company’s Board of Directors

3 years ago

ENGLEWOOD, CO / ACCESSWIRE / June 29, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and…

Altamira Therapeutics Secures Marketing & Distribution Agreements To Expand Sales Channels of Bentrio into Egypt and Pakistan

3 years ago

Two Additional Distributors Further Expand Company's Growing Global Footprint To Offer Its Bentrio Nasal Spray for Protection Against Airborne Allergens…

Elite Pharmaceuticals Receives FDA Approval for Generic Sabril(R)

3 years ago

NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical…

Healthcare Facilities Need a Holistic Digital Identity Strategy – Not Uncoordinated Solutions, New Imprivata Research Reveals

3 years ago

More than two-thirds believe identity management is important to their security strategy, yet less than half are using key identity…

BriaCell Enters Research Agreement to Identify Novel Targets for Cancer Treatment

3 years ago

PHILADELPHIA and VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”…

Ocuphire Granted New U.S. Patent for Late-Stage Oral Drug Candidate APX3330 for Use in Diabetics and Announces New Peer-Reviewed APX3330 Publication

3 years ago

Newly Issued Patent Broadens Medical Uses of Oral APX3330 Therapy in Patients with Diabetes and Extends Expiry Thru 2038 Peer-Reviewed…

Allied Corp Successfully Ships First Commercial Cannabis Flower Export From Colombia to International Market

3 years ago

KELOWNA, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to…

Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares and Pre-Funded Warrants

3 years ago

JERSEY, Channel Islands, June 29, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company"), a commercial-stage diagnostics company, announced…